Archives: 2020-02-19

PIER MARIA FORNASARI
2020-02-19

Johnson & Johnson to Expand Partnership with U.S. Department of Health & Human Services to Accelerate the Discovery of Potential COVID-19 Treatments

Janssen strengthens collaboration with Biomedical Advanced Research and Development Authority (BARDA) in an effort to stem the threat of the global COVID-19 outbreak Johnson & Johnson today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-02-19

New research on a promising treatment against type 1 diabetes funded by the European Commission with 6,8 million euros

Within the framework of a European funded H2020 project, VANGUARD aims to develop a cure for type 1 diabetes available to a larger group of patients. The VANGUARD project will use advanced tissue engineering techniques to generate a bioartificial pancreas, with the aim to propose a novel cell-based treatment to type 1 diabetes that overcomes

Read More

No Comments InTISSUE ENGINEERING
PIER MARIA FORNASARI
2020-02-18

Nivolumab Extends Survival in Pretreated Advanced Stomach Cancer Patients, Phase 3 Trial Results Show

The immune checkpoint inhibitor nivolumab may be a safe and effective treatment for people with advanced gastric or esophagogastric junction cancer who failed standard chemotherapy regimens, results from a Phase 3 clinical trial suggest. A three-year survival analysis of the trial, called ATTRACTION-2 (NCT02267343), showed that the treatment significantly extended patients’ lives and the time they

Read More

No Comments InIMMUNOTHERAPY
PIER MARIA FORNASARI
2020-02-17

Korea Institute of Medical Microrobotics researchers publish stem cell delivery via microrobot for knee cartilage surgery

Korean researchers have successfully demonstrated knee cartilage regeneration by using stem cells delivered by a magnet-controlled microrobot, raising hope to broaden a non-invasive procedure for patients who need invasive knee replacement surgery. The new method can also raise stem cell delivery accuracy efficiency by up to 95 percent compared to less than 20 percent in

Read More

No Comments InREGENERATIVE MEDICINE
PIER MARIA FORNASARI
2020-02-14

Africa prepares for Covid-19

With cases of Covid-19 spreading worldwide, governments and institutions are getting ready for the first cases in Africa. Munyaradzi Makoni reports from Cape Town in Lancet https://doi.org/10.1016/S0140-6736(20)30355-X “The risk and likelihood of getting an outbreak is very, very high”, said Ambrose Talisuna, the WHO Africa team lead for emergency preparedness. As of Feb 11, Africa

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-02-14

China develops convalescent plasma therapy for COVID-19 patients. The proposal was advanced by our website February the 7th

China has developed convalescent plasma to treat patients who are infected with the novel coronavirus (COVID-19), according to the China National Biotec Group. The company said they have collected plasma from some recovered patients to prepare therapeutic products including convalescent plasma and immune globulin. After strict blood biosafety tests, virus inactivation and antiviral activity tests,

Read More

No Comments InCORONAVIRUS CHINA
PIER MARIA FORNASARI
2020-02-14

Remdesivir prevents MERS coronavirus disease in monkeys

Results support testing antiviral against 2019 novel coronavirus. Source NIH The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), according to a new study from National Institutes of Health scientists. Remdesivir prevented disease when administered before infection and improved the condition of macaques when given after

Read More

No Comments InCORONAVIRUS CHINA